241 related articles for article (PubMed ID: 25743105)
21. High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.
Chen FM; Hou MF; Chang MY; Wang JY; Hsieh JS; Ou-Yang F; Huang TJ; Lin SR
Cancer Lett; 2005 Apr; 220(2):177-84. PubMed ID: 15766593
[TBL] [Abstract][Full Text] [Related]
22. Molecular Genetics of Pancreatic Neoplasms.
Hosoda W; Wood LD
Surg Pathol Clin; 2016 Dec; 9(4):685-703. PubMed ID: 27926367
[TBL] [Abstract][Full Text] [Related]
23. Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Beca F; Lee SSK; Pareja F; Da Cruz Paula A; Selenica P; Ferrando L; Gularte-Mérida R; Wen HY; Zhang H; Guerini-Rocco E; Rakha EA; Weigelt B; Reis-Filho JS
Histopathology; 2019 Dec; 75(6):931-937. PubMed ID: 31361912
[TBL] [Abstract][Full Text] [Related]
24. Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors.
Decker B; Karyadi DM; Davis BW; Karlins E; Tillmans LS; Stanford JL; Thibodeau SN; Ostrander EA
Am J Hum Genet; 2016 May; 98(5):818-829. PubMed ID: 27087322
[TBL] [Abstract][Full Text] [Related]
25. TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancer.
La Rosa S; Bernasconi B; Frattini M; Tibiletti MG; Molinari F; Furlan D; Sahnane N; Vanoli A; Albarello L; Zhang L; Notohara K; Casnedi S; Chenard MP; Adsay V; Asioli S; Capella C; Sessa F
Virchows Arch; 2016 Mar; 468(3):289-96. PubMed ID: 26586531
[TBL] [Abstract][Full Text] [Related]
26. Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Dewald GW; Smyrk TC; Thorland EC; McWilliams RR; Van Dyke DL; Keefe JG; Belongie KJ; Smoley SA; Knutson DL; Fink SR; Wiktor AE; Petersen GM
Mayo Clin Proc; 2009 Sep; 84(9):801-10. PubMed ID: 19720778
[TBL] [Abstract][Full Text] [Related]
27. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
[TBL] [Abstract][Full Text] [Related]
28. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
[TBL] [Abstract][Full Text] [Related]
29. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
30. Multiple loss of heterozygosity without K-ras mutation identified by molecular analysis on fine-needle aspiration cytology specimen of acinar cell carcinoma of pancreas.
Ohori NP; Khalid A; Etemad B; Finkelstein SD
Diagn Cytopathol; 2002 Jul; 27(1):42-6. PubMed ID: 12112815
[TBL] [Abstract][Full Text] [Related]
31. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma.
de Wilde RF; Ottenhof NA; Jansen M; Morsink FH; de Leng WW; Offerhaus GJ; Brosens LA
Mod Pathol; 2011 Sep; 24(9):1229-36. PubMed ID: 21572398
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
33. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T; Permuth-Wey J; Betts JA; Krischer JP; Fiorica J; Arango H; LaPolla J; Hoffman M; Martino MA; Wakeley K; Wilbanks G; Nicosia S; Cantor A; Sutphen R
Cancer; 2005 Dec; 104(12):2807-16. PubMed ID: 16284991
[TBL] [Abstract][Full Text] [Related]
36. Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series.
Yu R; Jih L; Zhai J; Nissen NN; Colquhoun S; Wolin E; Dhall D
Pancreas; 2013 Apr; 42(3):429-35. PubMed ID: 23462323
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association.
Gaujoux S; Tissier F; Ragazzon B; Rebours V; Saloustros E; Perlemoine K; Vincent-Dejean C; Meurette G; Cassagnau E; Dousset B; Bertagna X; Horvath A; Terris B; Carney JA; Stratakis CA; Bertherat J
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1888-95. PubMed ID: 21900385
[TBL] [Abstract][Full Text] [Related]
38. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.
Wang L; Tsutsumi S; Kawaguchi T; Nagasaki K; Tatsuno K; Yamamoto S; Sang F; Sonoda K; Sugawara M; Saiura A; Hirono S; Yamaue H; Miki Y; Isomura M; Totoki Y; Nagae G; Isagawa T; Ueda H; Murayama-Hosokawa S; Shibata T; Sakamoto H; Kanai Y; Kaneda A; Noda T; Aburatani H
Genome Res; 2012 Feb; 22(2):208-19. PubMed ID: 22156295
[TBL] [Abstract][Full Text] [Related]
39. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic mixed acinar-neuroendocrine carcinoma in a patient with a germline BRCA2 mutation: a case report.
Ikeda M; Miura S; Kume K; Kikuta K; Hamada S; Takikawa T; Nakagawa K; Unno M; Furukawa T; Masamune A
Clin J Gastroenterol; 2022 Oct; 15(5):999-1005. PubMed ID: 35819745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
